Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Breast Cancer Genes

Breast Cancer Genes Newsletter

Gene Solutions Concludes Successful ESMO Asia Congress 2025 with AI-Powered Multi-Omics Liquid Biopsy Symposium and Two Best Poster Awards 20 Dec 2025 03:43 GMT
… — Ho D. Vo 11P: BRCA1/BRCA2 pathogenic variant spectrum in 14 …
jscreen and the Mathew Forbes Romer Foundation Expand Multi-Year Partnership to Bring Lifesaving Genetic Testing Resources to South Florida 19 Dec 2025 20:13 GMT
… cancer risk through testing for BRCA1, BRCA2, and more than 60 other …
New study questions whether annual mammograms are necessary for most women 19 Dec 2025 14:23 GMT
… on genetics (sequencing of nine breast cancer genes) and other health factors. A …
Tolmar Announces Expanded Indication for Rubraca® (rucaparib) First and Only PARP Inhibitor to Outperform Docetaxel in a Head-to-Head Phase 3 Trial 19 Dec 2025 15:09 GMT
… ), in patients with mutations in BRCA1, BRCA2 or ATM. TRITON3 was designed … the presence of a germline BRCA2 mutation, a prognostic marker, have … prostate cancer, germline mutations in BRCA1 are also associated with more …
Zydus Signs Exclusive Pact with US-Based Myriad Genetics to Launch Cancer Diagnostic Tests in India 19 Dec 2025 12:06 GMT
… 63 clinically significant genes, including BRCA1, BRCA2, PALB2, ATM and TP53, covering …
Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India 19 Dec 2025 09:31 GMT
… analyses 63 clinically significant genes (BRCA1, BRCA2, PALB2, ATM, TP53, MLH1, MSH2 …
Zydus partners with Myriad Genetics to launch cancer-risk assessment diagnostic tests in India 19 Dec 2025 08:49 GMT
… analyses 63 clinically significant genes (BRCA1, BRCA2, PALB2, ATM, TP53, MLH1, MSH2 …
Zydus Lifesciences signs exclusive agreement with Myriad Genetics to launch advanced cancer genomic tests in India 19 Dec 2025 04:46 GMT
… 63 clinically significant genes, including BRCA1, BRCA2, PALB2, ATM, TP53, MLH1, and …
<![CDATA[Updated Treatment Options Improve Advanced HR+ Breast Cancer Outcomes ]]> 19 Dec 2025 02:05 GMT
… identify inherited mutations such as BRCA1, BRCA2 or PALB2, which can guide … , options include PARP inhibitors for BRCA1/2 or PALB2 mutations …
<![CDATA[FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC]]> 17 Dec 2025 21:41 GMT
… 405 patients with mCRPC harboring BRCA1, BRCA2, or ATM alterations who had …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS